Mesenchymal Stem Cells and NF-κB Sensing Interleukin-4 Over-Expressing Mesenchymal Stem Cells Are Equally Effective in Mitigating Particle-Associated Chronic Inflammatory Bone Loss in Mice

Wear particles from total joint arthroplasties (TJAs) induce chronic inflammation, macrophage infiltration and lead to bone loss by promoting bone destruction and inhibiting bone formation. Inhibition of particle-associated chronic inflammation and the associated bone loss is critical to the success and survivorship of TJAs. The purpose of this study is to test the hypothesis that polyethylene particle induced chronic inflammatory bone loss could be suppressed by local injection of NF-κB sensing Interleukin-4 (IL-4) over-expressing MSCs using the murine continuous polyethylene particle infusion model. The animal model was generated with continuous infusion of polyethylene particles into the intramedullary space of the femur for 6 weeks. Cells were locally injected into the intramedullary space 3 weeks after the primary surgery. Femurs were collected 6 weeks after the primary surgery. Micro-computational tomography (μCT), histochemical and immunohistochemical analyses were performed. Particle-infusion resulted in a prolonged pro-inflammatory M1 macrophage dominated phenotype and a decrease of the anti-inflammatory M2 macrophage phenotype, an increase in TRAP positive osteoclasts, and lower alkaline phosphatase staining area and bone mineral density, indicating chronic particle-associated inflammatory bone loss. Local injection of MSCs or NF-κB sensing IL-4 over-expressing MSCs reversed the particle-associated chronic inflammatory bone loss and facilitated bone healing. These results demonstrated that local inflammatory bone loss can be effectively modulated via MSC-based treatments, which could be an efficacious therapeutic strategy for periprosthetic osteolysis.

[1]  S. Goodman,et al.  Suppression of NF-κB-induced chronic inflammation mitigates inflammatory osteolysis in the murine continuous polyethylene particle infusion model. , 2021, Journal of biomedical materials research. Part A.

[2]  S. Goodman,et al.  Different Effects of Intramedullary Injection of Mesenchymal Stem Cells During the Acute vs. Chronic Inflammatory Phase on Bone Healing in the Murine Continuous Polyethylene Particle Infusion Model , 2021, Frontiers in Cell and Developmental Biology.

[3]  Zhenzhen Wang,et al.  Modulating macrophage activities to promote endogenous bone regeneration: Biological mechanisms and engineering approaches , 2020, Bioactive materials.

[4]  S. Goodman,et al.  Modulation of the Inflammatory Response and Bone Healing , 2020, Frontiers in Endocrinology.

[5]  L. Qin,et al.  ZBTB20-mediated titanium particle-induced peri-implant osteolysis by promoting macrophage inflammatory responses. , 2020, Biomaterials science.

[6]  R. Wong,et al.  Impaired Fracture Healing in Sarco‐Osteoporotic Mice Can Be Rescued by Vibration Treatment Through Myostatin Suppression , 2020, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[7]  R. Wong,et al.  Vibration treatment modulates macrophage polarisation and enhances early inflammatory response in oestrogen-deficient osteoporotic-fracture healing. , 2019, European cells & materials.

[8]  S. Goodman,et al.  Inflammation and Bone Repair: From Particle Disease to Tissue Regeneration , 2019, Front. Bioeng. Biotechnol..

[9]  Fan Yang,et al.  Preconditioned or IL4-Secreting Mesenchymal Stem Cells Enhanced Osteogenesis at Different Stages. , 2019, Tissue engineering. Part A.

[10]  M. Glogauer,et al.  An Overview of the Derivation and Function of Multinucleated Giant Cells and Their Role in Pathologic Processes. , 2019, The American journal of pathology.

[11]  Dan-dan Li,et al.  Improved therapeutic potential of MSCs by genetic modification , 2018, Gene Therapy.

[12]  S. Goodman,et al.  NFκB sensing IL-4 secreting mesenchymal stem cells mitigate the proinflammatory response of macrophages exposed to polyethylene wear particles. , 2018, Journal of biomedical materials research. Part A.

[13]  Jiake Xu,et al.  TNF-α inhibits SATB2 expression and osteoblast differentiation through NF-κB and MAPK pathways , 2017, Oncotarget.

[14]  S. Goodman,et al.  Orthopaedic wear particle-induced bone loss and exogenous macrophage infiltration is mitigated by local infusion of NF-κB decoy oligodeoxynucleotide. , 2017, Journal of biomedical materials research. Part A.

[15]  S. Goodman,et al.  * Murine Model of Progressive Orthopedic Wear Particle-Induced Chronic Inflammation and Osteolysis. , 2017, Tissue engineering. Part C, Methods.

[16]  S. Goodman,et al.  Establishment of NF-κB sensing and interleukin-4 secreting mesenchymal stromal cells as an "on-demand" drug delivery system to modulate inflammation. , 2017, Cytotherapy.

[17]  Fan Yang,et al.  Mutant CCL2 protein coating mitigates wear particle-induced bone loss in a murine continuous polyethylene infusion model. , 2017, Biomaterials.

[18]  R. Miron,et al.  Giant cells around bone biomaterials: Osteoclasts or multi-nucleated giant cells? , 2016, Acta biomaterialia.

[19]  S. Goodman,et al.  NF-κB decoy oligodeoxynucleotide mitigates wear particle-associated bone loss in the murine continuous infusion model. , 2016, Acta biomaterialia.

[20]  Fan Yang,et al.  The effect of local IL-4 delivery or CCL2 blockade on implant fixation and bone structural properties in a mouse model of wear particle induced osteolysis. , 2016, Journal of biomedical materials research. Part A.

[21]  S. Goodman,et al.  NF-κB decoy oligodeoxynucleotide inhibits wear particle-induced inflammation in a murine calvarial model. , 2015, Journal of biomedical materials research. Part A.

[22]  Y. Konttinen,et al.  Establishment of Green Fluorescent Protein and Firefly Luciferase Expressing Mouse Primary Macrophages for In Vivo Bioluminescence Imaging , 2015, PloS one.

[23]  Xiaobing Fu,et al.  LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b , 2015, Journal of Translational Medicine.

[24]  S. Goodman,et al.  NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. , 2015, Tissue engineering. Part A.

[25]  S. Shi,et al.  Immunomodulation regulates mesenchymal stem cell-based bone regeneration. , 2014, Oral diseases.

[26]  Edmund Lau,et al.  Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021. , 2014, The Journal of bone and joint surgery. American volume.

[27]  Fan Yang,et al.  Novel biological strategies for treatment of wear particle-induced periprosthetic osteolysis of orthopaedic implants for joint replacement , 2014, Journal of The Royal Society Interface.

[28]  Y. Abu-Amer NF-κB signaling and bone resorption , 2012, Osteoporosis International.

[29]  S. Goodman,et al.  The basic science of periprosthetic osteolysis. , 2013, Instructional course lectures.

[30]  S. Gambhir,et al.  MC3T3-E1 osteoprogenitor cells systemically migrate to a bone defect and enhance bone healing. , 2012, Tissue engineering. Part A.

[31]  S. Goodman,et al.  Continuous Infusion of UHMWPE Particles Induces Increased Bone Macrophages and Osteolysis , 2011, Clinical orthopaedics and related research.

[32]  Victor M. Goldberg,et al.  Bacterial Pathogen-associated Molecular Patterns Stimulate Biological Activity of Orthopaedic Wear Particles by Activating Cognate Toll-like Receptors* , 2010, The Journal of Biological Chemistry.

[33]  Zhaojun Wang,et al.  Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress‐induced apoptosis and enhance proliferation of MSCs via Toll‐like receptor(TLR)‐4 and PI3K/Akt , 2009, Cell biology international.

[34]  Jiake Xu,et al.  NF-kappaB modulators in osteolytic bone diseases. , 2009, Cytokine & growth factor reviews.

[35]  D. Lindsey,et al.  An in vivo murine model of continuous intramedullary infusion of polyethylene particles. , 2008, Biomaterials.

[36]  S. Goodman Wear particles, periprosthetic osteolysis and the immune system. , 2007, Biomaterials.

[37]  M. Pevsner-Fischer,et al.  Toll-like receptors and their ligands control mesenchymal stem cell functions. , 2007, Blood.

[38]  J. Ferluga,et al.  The role of macrophage activation in chronic inflammation , 2005, Agents and Actions.

[39]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[40]  V. Goldberg,et al.  Adherent Endotoxin on Orthopedic Wear Particles Stimulates Cytokine Production and Osteoclast Differentiation , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.